These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8290266)

  • 1. A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia.
    Jacobson DR; Mills NE
    Oncogene; 1994 Feb; 9(2):553-63. PubMed ID: 8290266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
    Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
    Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma.
    Mills NE; Fishman CL; Rom WN; Dubin N; Jacobson DR
    Cancer Res; 1995 Apr; 55(7):1444-7. PubMed ID: 7882350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative enriched PCR (QEPCR), a highly sensitive method for detection of K-ras oncogene mutation.
    Ronai Z; Minamoto T
    Hum Mutat; 1997; 10(4):322-5. PubMed ID: 9338587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
    Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
    Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique.
    Behn M; Qun S; Pankow W; Havemann K; Schuermann M
    Clin Cancer Res; 1998 Feb; 4(2):361-71. PubMed ID: 9516924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parental exposure to medications and hydrocarbons and ras mutations in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
    Shu XO; Perentesis JP; Wen W; Buckley JD; Boyle E; Ross JA; Robison LL;
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1230-5. PubMed ID: 15247135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification.
    Kahn SM; Jiang W; Culbertson TA; Weinstein IB; Williams GM; Tomita N; Ronai Z
    Oncogene; 1991 Jun; 6(6):1079-83. PubMed ID: 1676837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.
    Keohavong P; Zhu D; Whiteside TL; Swalsky P; Bakker A; Elder EM; Siegfried JM; Srivastava S; Finkelstein SD
    Anal Biochem; 1997 May; 247(2):394-403. PubMed ID: 9177704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of K-ras point mutation by enriched PCR-colorimetric plate assay.
    Santiago FS; Todd AV; Hawkins NJ; Ward RL
    Mol Cell Probes; 1997 Feb; 11(1):33-8. PubMed ID: 9076712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid detection of exon 1 NRAS gene mutations using universal heteroduplex generator technology.
    Belli C; De Brasi C; Larripa I
    Hum Mutat; 2003 Feb; 21(2):132-7. PubMed ID: 12552560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay.
    Asano H; Toyooka S; Tokumo M; Ichimura K; Aoe K; Ito S; Tsukuda K; Ouchida M; Aoe M; Katayama H; Hiraki A; Sugi K; Kiura K; Date H; Shimizu N
    Clin Cancer Res; 2006 Jan; 12(1):43-8. PubMed ID: 16397022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 mutations in lung tumors: relationship to putative susceptibility markers for cancer.
    Ryberg D; Kure E; Lystad S; Skaug V; Stangeland L; Mercy I; Børresen AL; Haugen A
    Cancer Res; 1994 Mar; 54(6):1551-5. PubMed ID: 8137262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative detection of mutant alleles of the K-ras gene with minor groove binder-conjugated fluorogenic DNA probes.
    Itabashi T; Maesawa C; Uchiyama M; Higuchi T; Masuda T
    Int J Oncol; 2004 Mar; 24(3):687-96. PubMed ID: 14767554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis.
    Bezieau S; Devilder MC; Avet-Loiseau H; Mellerin MP; Puthier D; Pennarun E; Rapp MJ; Harousseau JL; Moisan JP; Bataille R
    Hum Mutat; 2001 Sep; 18(3):212-24. PubMed ID: 11524732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allele-specific enrichment: a method for the detection of low level N-ras gene mutations in acute myeloid leukemia.
    Todd AV; Ireland CM; Iland HJ
    Leukemia; 1991 Feb; 5(2):160-1. PubMed ID: 2020198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ras gene activation in a minor proportion of the blast population in acute myeloid leukemia.
    Toksoz D; Farr CJ; Marshall CJ
    Oncogene; 1987; 1(4):409-13. PubMed ID: 3330783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes.
    Kumar R; Dunn LL
    Oncogene Res; 1989; 4(3):235-41. PubMed ID: 2567980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.